GPAA1 Activators

GPAA1 Modulators comprises various compounds that can indirectly influence the activity of Glycosylphosphatidylinositol Anchor Attachment 1 (GPAA1). GPAA1 is involved in the GPI anchoring process, a post-translational modification where GPI anchors are attached to proteins, targeting them to the cell membrane. The compounds listed here do not directly activate GPAA1 but affect related biosynthetic pathways and cellular processes.

ManNAc (N-Acetylmannosamine) and Tunicamycin are involved in glycosylation processes. ManNAc plays a role in glycan synthesis, while Tunicamycin inhibits N-linked glycosylation. Both can indirectly impact the GPI-anchor biosynthesis pathway and, therefore, the function of GPAA1. Brefeldin A and Monensin disrupt Golgi function, a critical organelle in GPI-anchor attachment, affecting GPAA1 activity. Swainsonine and Castanospermine can impact the processing of GPI anchors. By inhibiting enzymes like mannosidase and glucosidase, these compounds may indirectly affect GPI-anchor biosynthesis and GPAA1 function. PUGNAc and NB-DNJ also influence the glycosylation processes relevant to GPI-anchor attachment.